跳至主要内容
临床试验/CTRI/2024/03/064455
CTRI/2024/03/064455尚未招募2 期

An Anatomical Study on Kukundara Marma with special reference to Katishoola (Low Back Pain)

Institute of Medical Science1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年4月10日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
50
试验地点
1
主要终点
Relief in sign and symptoms of the disease. The main sign and symptoms in the study are as follow

研究概览

简要总结

50 cases of Katishoola (Low Back Pain) will be included in this interventional study which will be randomly divided in to two groups of 25 patients in each group. One group will be prescribed Tryodashanga Guggulu and Dashmoola Kwath. Second group will be prescribed Tryodashanga Guggulu, Dashmoola Kwath and Kukundara Marma Chikitsa.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • clinical symptoms with or without radiological changes.

排除标准

  • Patients below 20 years and above 70 years of age will be excluded.
  • Patient suffering from paralysis.
  • Uncontrolled diabetes mellitus, cardiovascular disease, neoplastic disorder, any severe illness.
  • Pregnancy
  • Severe malnourished, debilitated 6.

结局指标

主要结局

Relief in sign and symptoms of the disease. The main sign and symptoms in the study are as follow

时间窗: 30 days study with follow up at 15 days

Pain in Kati(lumbar region)

时间窗: 30 days study with follow up at 15 days

Stiffness in Kati

时间窗: 30 days study with follow up at 15 days

Numbness

时间窗: 30 days study with follow up at 15 days

Tingling sensation

时间窗: 30 days study with follow up at 15 days

Headache

时间窗: 30 days study with follow up at 15 days

Weakness of lower limbs

时间窗: 30 days study with follow up at 15 days

Giddiness

时间窗: 30 days study with follow up at 15 days

次要结局

  • education in scoring of following scale;(Visual Analog Scale)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Ragini devi pal

Institute of Medical Science BHU

研究点 (1)

Loading locations...

相似试验

Press Kukundara Marma situated in low back region... | 临床试验